COMPUTEX
4.6.2021 12:05:06 CEST | Business Wire | Press release
The second day of COMPUTEX Forum, organized by TAITRA, featured "Critical Technology" and "Tomorrow Tech." World-renown tech leaders such as Qualcomm, QCT, WIN Semiconductors Corp., Siemens, Far EasTone Telecom, NVIDIA, and IBM shared their perspectives on the latest development of 5G, AI & IoT, and quantum computing, as well as their strategies for navigating in the new normal.
Cynthia Kiang, Director General of the Bureau of Foreign Trade, MOEA, Taiwan, said in her opening remarks that the recent global chip shortage underscores the importance of supply chain resilience, and that international cooperation is the best way to ensure supply chain efficiency and stability. She expects COMPUTEX to be a platform that helps with integrating global resources, allowing ecosystem partners to explore future business opportunities.
Qualcomm: Empowering the future of PC with mobile computing
With the onset of the pandemic and shift to remote working and learning, the way people use PCs has rapidly expanded. Alex Katouzian, Senior Vice President and General Manager of Mobile, Compute, and Infrastructure for Qualcomm Technologies, shared his unique perspectives on how 5G along with always connected PC are facilitating connectivity, mobility, and productivity as PC becomes the best collaborative tool in a mobile office. Qualcomm will also continue to collaborate with its ecosystem partners to realize the future of always connected PC.
QCT: 5G New Era: Great Convergence, Broad Ecosystem, Golden Opportunity
Mike Yang, President of QCT, talks about the great convergence of IT and CT, and the many new entrants into the Telco ecosystem that are changing our daily lives. With them more and more service providers will push for digital transformation and build 5G networks that will open up new opportunities for everyone, including operators and enterprises.
WIN Semiconductors Corp: Shaping the future with compound semiconductors
Dr. Yu-Chi (YC) Wang, Vice Chairman of WIN Semiconductors Corp emphasized that compound semiconductors are essential in realizing a life style built on seamless connection, precise sensing, and efficiency power. In addition, future life will be based on ubiquitous AI access with 6G, super IoT, and AI. Compound semiconductor will play a pivotal role to advance that future.
Siemens: Industrial 5G, Grid Edge and Connected Mobility will accelerate smart economy development and drive industrial innovation and transformation
Taiwan is crucial in the global supply chain of ICT components with a comprehensive industrial value chain. Erdal Elver, President and CEO of Siemens Taiwan pointed out that Taiwan has a clear advantage in introducing 5G innovative applications in manufacturing and city infrastructure. Siemens’ world-leading technologies and success stories in Industrial 5G, Grid Edge and Connected Mobility will assist Taiwan in ushering in application innovation in a variety of fields, helping Taiwan move toward its vision of "Digital Nation, Smart Island."
Far EasTone Telecom: Enabling clinical intelligence through telemedicine with 5G, IoT, big data, and AI
Chee Ching, President of Far EasTone Telecom, discussed medical applications in the 5G era. Telemedicine supported by 5G is capable of diagnosing patients remotely through features such as high resolution, big bandwidth, low latency, and massive connectivity. Telemedicine will also be able to detect and prevent diseases using big data and AIoT, ushering a new era of smart medicine. Chee Ching also pointed out that long-term care will be the extended application field for telehealth. With Taiwan expected to become a super-aged society by 2026, Far EasTone Telecom views this not only as a business opportunity but also as a social responsibility.
NVIDIA: Empowering collaboration across shared virtual worlds by addressing 3D workflows
Richard Kerris, NVIDIA Head of Worldwide Developer Relations and General Manager of Omniverse, indicated that a distributed workforce has become the norm with the rise of hybrid work. Remote working, however, has deepened the challenges of 3D workflows. NVIDIA Omniverse, the revolutionary new platform for virtual collaboration and simulation, can empower individuals and companies across multiple industries to address the challenges of complex 3D workflows by connecting users, content creation tools, and enabling AI to be used across shared virtual worlds.
IBM: Quantum computing
Norishige Morimoto, Vice President of IBM Research and Development of Japan, stated that quantum computing has yet to overcome obstacles on hardware and application development before becoming available for all. Now, IBM is collaborating with industry and universities including NTU, focusing on finance, chemistry, material industries.
2021 COMPUTEX Forum and keynote speeches are all available for viewing on #COMPUTEXVirtual online platform and COMPUTEX YouTube channel from now.
For more information:
COMPUTEX : https://www.computextaipei.com.tw/
InnoVEX : https://www.innovex.com.tw/
About COMPUTEX
Established in 1981, COMPUTEX is one of the leading global ICT, IoT, and startup tradeshows with a complete supply chain and IoT ecosystems. Co-organized by the Taiwan External Trade Development Council (TAITRA) and Taipei Computer Association (TCA), COMPUTEX, based upon Taiwan’s complete ICT clusters, covers the whole spectrum of the ICT industry, from established brands to startups and from ICT supply chain to IoT ecosystems. With strong R&D and manufacturing capabilities and IPR protection, Taiwan is a strategic destination for foreign companies and investors looking for partners in global technology ecosystems. Follow COMPUTEX on its website at www.computextaipei.com.tw and Twitter @computex_taipei using the hashtag #COMPUTEX.
About COMPUTEX 2021 Virtual
As a pioneer in technology, COMPUTEX has been at the forefront in embracing digital transformation. In 2021, the show will go online. Together with the key global technology players, the organizer of COMPUTEX,Taiwan External Trade Development Council (TAITRA) introduces #COMPUTEXVirtual (including its global startups and innovations showcase #InnovexVirtual), an AI-driven virtual platform, and aims to deliver an exceptional virtual exhibition experience beyond the distance.
Explore #COMPUTEXVirtual now at https://virtual.computextaipei.com.tw/ .
About TAITRA
Founded in 1970, TAITRA is Taiwan's foremost nonprofit trade promoting organization. Sponsored by the government and industry organizations, TAITRA assists enterprises to expand their global reach. Headquartered in Taipei, TAITRA has a team of 1,300 specialists and operates 5 local offices in Taoyuan, Hsinchu, Taichung, Tainan and Kaohsiung, as well as 63 branches worldwide. Together with Taipei World Trade Center (TWTC) and Taiwan Trade Center (TTC), TAITRA has formed a global network dedicated to promoting world trade.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210604005260/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer House of Code for at styrke teknologi- og dataløsninger26.6.2026 20:01:00 CEST | Pressemeddelelse
Andersen Consulting forstærker sine kompetencer inden for teknologisk transformation gennem en samarbejdsaftale med House of Code, en global virksomhed med hovedkvarter i USA, der specialiserer sig i datadrevne platforme, automatisering og agentbaserede ai-løsninger. House of Code blev stiftet i 2001 og udvikler softwareløsninger samt yder rådgivning til energihandels- og finanssektoren med kunder, der spænder over hedgefonde, kapitalfonde og forsyningsvirksomheder. Virksomheden besidder dyb ekspertise inden for energihandel og risikostyring og hjælper organisationer med systemimplementering, forretningstransformation, dataautomatisering og ai-underbygget modernisering af arbejdsgange. Deres proprietære platform, Enterprise Platform for Integrated Compliance (EPIC), skaber en mere effektiv datastyring, automatiserer rapporteringsprocesser, forbedrer den driftsmæssige gennemsigtighed på tværs af virksomhedssystemer og skaber et fundament for opbygning af intelligente, agentbaserede arbe
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 20:00:00 CEST | Press release
Receives AI Governance & Risk Excellence Award at OpenAI Partner SummitCapco’s UK AI Lab wins OpenAI Codex Hackathon Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solutio
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom